baber/WOPTO huggingface dataset:
Patent NZ-576472-A (NZ)
Title: Pump system for negative pressure wound therapy
Inventor: KARPOWICZ JOHN R
IPC: A61M1/00
Filed: 2007-01-12
Abstract: A system for applying suction to a wound comprises a portable suction pump for producing negative pressure. The pump (203) comprises (a) a flow rate monitoring system (210), (b) a visual indicator (214) and (c) a pressure control circuit (206). The flow rate monitoring system measures airflow through a conduit from a wound dressing to the pump and detects whether the airflow is within a reference flow rate range, below the reference flow rate range, or above the reference flow rate range. The visual indicator indicates occlusion when the airflow is below the reference flow rate range, normal operation when the airflow is within the reference flow rate range and leakage when the airflow is above the reference flow rate range. The pressure control circuit controls the operation of the pump to maintain the pressure sensed by a pressure transducer at the pump inlet between upper and lower limits around a pressure set-point.
Patent NZ-578596-A (NZ)
Title: A wireless device for use in a multicast acknowledged wireless communications network which is user switchable between a repeater mode and a non-repeater mode
Inventor: GERARD JASON
IPC: H04B7/005
Filed: 2008-02-06
Abstract: A wireless device for use in a multicast acknowledged wireless communications network is disclosed. The wireless device includes: an antenna for receiving and transmitting data; a transceiver for receiving and transmitting the data to or from the antenna; a microprocessor for processing the data in accordance with a communications protocol in a non-repeater communications mode and in a repeater mode; and an input device for switching the wireless device between a non-repeater communications mode and a repeater mode. In use, the wireless device is able to be selectively switched between a non-repeater communications mode and a repeater mode by a person actuating the input device.
Patent NZ-580271-A (NZ)
Title: Process for making galantamine
Inventor: WANG LUNGHU
IPC: A61K31/55
Filed: 2008-04-02
Abstract: Disclosed is a process for the preparation of a compound of Formula I wherein Z is a blocking group, comprising: activating a compound of the Formula II, wherein Z is defined as above, with a coupling agent to give an activated compound of the Formula III, wherein X is a leaving group resulting from the use of the coupling agent and coupling the activated compound of Formula III with a compound N-methyl-N-(2-[4-hydroxyphenyl]ethyl) amine or acid salt of this compound to give compound of the Formula I. Also disclosed is process of making (-)-galantamine comprising said process.
Patent NZ-582354-A (NZ)
Title: Non-rotating nutating plate pump with compound spherical bearing
Inventor: DALZIEL LINDSAY BRUCE
IPC: F04B19/04
Filed: 2009-12-24
Abstract: A swash pump or turbine includes an inner swash sphere 103 supporting an annular swash plate 103A and having a central aperture 103B. The swash plate is housed within an enclosed pumping chamber 105 enclosed on each side by a fixed cone plate 101, 107 in the shape of a shallow cone so that the plate is enclosed outwardly by the internal surface 106 of a fixed partial sphere housing. The inner swash sphere nutates as the slanted section 102A of the rotatable common drive shaft 102 is rotated within the central aperture 103B whilst maintaining moving sealing lines between the swash plate and the cone plates. The common drive shaft 102 is entirely supported by two bearing elements being (A) a compound bearing supporting the swash plate and having an outer part which is the outer surface of the inner swash sphere slidably supported upon two concave part spherical bearings 109, 109A that are in turn supported against the housing and an inner part being journalled bearings 108 within the central aperture 103B of the inner swash sphere that rotatably support the slanted section of the drive shaft, and (B) a single bearing 110 rotatably supporting the straight section of the common drive shaft against the housing.
Patent NZ-594587-A (NZ)
Title: Process for the synthesis of cleistanthin
Inventor: SINGH OM VIR
IPC: A61K31/343
Filed: 2010-02-04
Abstract: Disclosed is a process for preparing compound of formula I, wherein the process comprises the steps of reacting compound of formula II with compound of formula III in the presence of a first solvent (dichloromethane), quartenary ammonium salt (tetrabutyl ammonium bromide) and first alkali (sodium hydroxide) to form compound of formula IV; treating compound of formula IV with a second alkali (potassium carbonate) and a second solvent (methanol) to form compound of formula I. Compound of formula I is Cleistanthin (a diphyllin glycoside) (9-(1,3-benzodioxol-5-yl)-4-((3,4-di-O-methyl-D-xylopyranosyl)oxy)-6,7-dimethoxynaphtho(2,3-c)furan-1(3H)-one). Compound of formula II is 9-(3',4'-Methylenedioxyphenyl)-4-hydroxy-6,7-dimethoxynaphtho[2,3-c]furan-1 (3H)-one. Compound of formula III is 2-O-Acetyl-3, 4-dimethoxy-alpha-D-bromoxylopyranose. Compound of formula IV is Cleistanthin A acetate (9-(1,3-Benzodioxo 1-5-yl )-4((3 ,4-di -O-methyl-D-xylopyranosyl)acetate )-6,7-dimethoxynaphtho(2,3-c)furan-1(3H)-one).
Patent NZ-595608-A (NZ)
Title: Chair for a ski lift with a safety bar and a footrest below the seat connected to an automatic positioning mechanism
Inventor: HINTEREGGER CHRISTOPH
IPC: B60N2/90
Filed: 2011-10-06
Abstract: A chair (3) of a chairlift including at least one seat (5) with a seat surface and a safety bar (10) which extends transversely over the seat (5) and may be pivoted from an open position into a closed position. The seat also includes at least one footrest (6) connected to an automatic positioning mechanism. The footrest may be adjusted below the seat (5) between a travel position and a boarding and/or disembarking position. A method of operating a chairlift with such a chair is also disclosed.
Patent NZ-596486-A (NZ)
Title: Unobtrusive nasal mask
Inventor: BARLOW ADAM
IPC: A61M16/06
Filed: 2010-06-02
Abstract: 596486 A patient interface (200) for delivering breathable gas to a patient includes a sealing portion (210) including a nose tip engagement portion adapted to form a seal with the patient’s nose tip, an upper lip engagement portion adapted to form a seal with the patient’s upper lip and/or base of the patient’s nares, and nostril engagement flaps adapted to form a seal with the patient’s nares. The nose tip engagement portion, the upper lip engagement portion, and the nostril engagement flaps are all structured to extend outwardly from a supporting wall such that an area defined by an outer periphery of the sealing portion at a patient engaging side is greater than an area defined by an outer periphery of the sealing portion at a supporting wall engaging side, and wherein the supporting wall defines an air path.
Patent NZ-596497-A (NZ)
Title: New therapeutical uses of inecalcitol
Inventor: DELANSORNE REMI
IPC: A61K31/593
Filed: 2010-05-18
Abstract: Disclosed is vitamin D analogue inecalcitol (depicted) for use for treating and/or preventing rickets, osteoporosis, osteomalacia, psoriasis, autoimmune diseases such as multiple sclerosis or type I diabetes, hyperparathyroidism, benign prostate hyperplasia, any type of cancer or any vitamin D associated disease, at doses comprised between 1.5 mg and 100 mg.
Patent NZ-602932-A (NZ)
Title: Targeted pyrrolobenzodiazapine conjugates
Inventor: JEFFREY SCOTT
IPC: A01N29/06
Filed: 2011-04-15
Abstract: Disclosed herein is a conjugate of formula I, L – (LU-D)p, wherein L is a cell binding agent that specifically binds to a target molecule on the surface of a target cell, LU is a Linker unit, p is 1 to 20; and D is a Drug unit comprising a PBD dimer of formula II, wherein the variable are defined herein. Additionally disclosed is the use of the conjugate in the treatment of a proliferative or autoimmune disease. Specific embodiments of the conjugate include (E)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N’-(4-((S)-7-methoxy-8-((5-(((S)-7-methoxy-2-(4-methoxyphenyl)-5-oxo-5,11a-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-5-oxo-5,11a-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)benzylidene)hexanehydrazide.
Patent NZ-615162-A (NZ)
Title: A stroller frame with an automatic brake mechanism actuatable by hand detecting
Inventor: WEI-YEH LI
IPC: B62B9/08
Filed: 2013-09-05
Abstract: Disclosed is a stroller frame with an automatic brake mechanism which is activated when a user releases a handle of the stroller. The stroller frame with an automatic brake mechanism includes at least a first rear wheel (11) with a first locking mechanism (2), and a second rear wheel (12) with a second locking mechanism (3), a battery (4) and a hand-detecting handle (5). The first and second locking mechanisms each comprise an electromagnet (see 21, figure 11) and a locking pin (see 22, figure 11) which engage with positioning holes (see 110, figure 11) of the first and second rear wheels. The hand-detecting handle is capable of detecting the caregiver’s hand by a change of capacitance on its surface. A power supply circuit (41) may provide currents in different direction to the first locking mechanism and the second locking mechanism, so as to automatically lock the rear wheels once the caregiver’s hand has left the hand-detecting handle, and automatically unlock the rear wheels when the caregiver’s hand near the hand-detecting handle. This automatically locking function prevents the stroller accidentally rolling away from the caregiver.
Patent NZ-620015-A (NZ)
Title: Tap
Inventor: BELLMORE DAVID
IPC: B67D3/04
Filed: 2010-07-14
Abstract: 620015 Disclosed is a tap (10) for use in association with bag in box containers such as containers for wine. Current taps fail to effectively maintain an upper seal which then leads to leakage when in use. Further, many taps fail to prevent dripping after use when the tap is closed. The tap (10) comprises a body (12); a plug member (14); an upper seal assembly and a lower seal assembly. The body (12) has a tap nozzle (24) in the form of an elongated tube (50). The elongated tube (50) has an inner surface (56) and outer surface (58). A handle opening (53) is disposed at a first end (52) of the elongated tube (50) and a dispensing means (55) at a second end (54) thereof. A nozzle opening (48) extends into the elongated tube (50) between the first (52) and second (54) ends. The nozzle opening (48) is capable of being placed in fluid communication with a bag of the bag in box container. The plug member (14) has a first end (74), second end (76) and outer surface. The plug member (14) is structurally configured to fit within the elongated tube (50) of the body (12) such that the outer surface of the plug member (14) faces the inner surface (56) of the elongated tube (50). The plug member (14) is also configured to be slidably movable within the elongated tube (50) of the body (12) between a closed orientation and an open orientation. When in the open orientation, the nozzle opening (48) is in fluid communication with the dispensing opening (55). When in the closed orientation the nozzle opening (48) is prevented from communicating fluidly with the dispensing opening (55). The upper seal assembly comprises an upper seal surface region (60) which is positioned on the inner surface (56) of the elongated tube (50) between the nozzle opening (48) and the handle opening (53) of the body (12). An upper seal bead (90) is positioned on the outer surface of the plug member (14). The upper seal assembly maintains continuous sealing engagement between the closed orientation and the open orientation of the tap (10). The lower seal assembly seals the tap nozzle (24) and the plug member (14) between the nozzle opening (48) and the dispensing opening (55). The upper seal surface region (60) is curved so that an interference between the upper seal surface region (60) and the upper seal bead (90) increases proximate the closed position and the open position and decreases between the two positions.
Patent NZ-623058-A (NZ)
Title: Preparation method for polyester/polyvinyl glyoxal hot melt adhesive having a semi-interpenetrating network structure
Inventor: LI ZHELONG
IPC: C09J167/02
Filed: 2013-06-20
Abstract: A polyester/polyvinyl glyoxal hot melt adhesive having a semi-interpenetrating network structure and preparation technique therefor, mainly comprising the following steps: 1) placing a certain amount of dimethyl terephthalate and other dibsic esters, 1,4-butanediol and other diols, and an organic tin catalyst into a reactor, conducting an ester exchange reaction under the protection of nitrogen till the distillate quantity of the byproduct, monohydric alcohol, is above the theoretical quantity of 95%, and ending the ester exchange reaction; 2) maintaining the temperature for a period, adding a stabilizer and a polycondensation catalyst, continuing to raise the reaction temperature, performing polycondensation under a reduced pressure to obtain copolymer particles, and freezing and crushing to obtain copolymer powder; 3) adding a mixture of polyvinyl alcohol (PVA)/oxalic acid to the product of step 2), stirring under the normal temperature to make even, and producing the target product. The product can form a semi-interpenetrating network structure under an operation temperature.
Patent NZ-625199-A (NZ)
Title: Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides
Inventor: BEAUPREZ JOERI
IPC: C12R1/19
Filed: 2012-12-14
Abstract: Disclosed is the use of a modified expression of the transcriptional regulators; the aerobic respiration control protein ArcA and the isocitrate lyase regulator IclR, to upregulate at least one of the genes of the colanic acid operon, wherein said operon comprises the genes cpsG, cpsB, gmd and fcl that code for a phosphomannomutase, a mannose-1-phosphate guanylyltransferase, GDP-mannose 4,6-dehydratase and GDP-fucose synthase, respectively. Further disclosed is a process for the synthesis of colanic acid and/or GDP-fucose and/or fucosylated oligosaccharides comprising: genetically changing the transcriptional regulators, the aerobic respiration control protein ArcA, and the isocitrate lyase regulator IclR, to upregulate at least one of the genes of the colanic acid operon, wherein said operon comprises the genes cpsG, cpsB, gmd and fcl. Further disclosed is a mutated and/or transformed bacterium in which the regulators ArcA and IclR, in combination with the genes encoding for the enzymes phosphoglucose isomerase and phosphofructokinase, are knocked out or are rendered less functional. Further disclosed is the use of a modified expression of the transcriptional regulators the aerobic respiration control protein ArcA and the isocitrate lyase regulator IclR, to upregulate at least one of the following acid resistance related genes: ydeP, ydeO, hdeA, hdeD, gada, gadC, gadE, gadX, gadWand/or slp.
Patent NZ-627102-A (NZ)
Title: Gender-specific identification of sperm cells and embryos using locked nucleic acids
Inventor: DIDION BRADLEY
IPC: A61B10/00
Filed: 2013-01-03
Abstract: Disclosed are methods for gender specifically separating a population of sperm cells or non-human embryos. Said methods comprise contacting the population with a labelled locked nucleic acid capable of binding to gender-specific tandem repeat sequences in a portion of the population to provide a labelled fraction and an unlabelled fraction, then separating the labelled from the unlabelled. Also disclosed are sperm cells and non-human embryos comprising a labelled locked nucleic acid bound to a gender-specific repeat sequence
Patent NZ-701010-A (NZ)
Title: A fluorescence microtitre plate reader
Inventor: MOZOLOWSKI GUY
IPC: G01N21/64
Filed: 2013-04-01
Abstract: A fluorescence microtitre plate reader comprises a plate reader body (2) having a base (3), top (5) and sidewalls (4), the top of the plate reader comprising at least one seat (6) dimensioned for receipt of a microtitre plate (7), the at least one seat defining an aperture (8) in the top of the plate that substantially corresponds to a base of the plate. The plate reader also includes means for illuminating wells of a microtitre plate with light from beneath the plate having an excitation wavelength, and a camera (10) and lens (11) assembly for capturing light emitted by the wells of the microtitre plate and generating a digital image, in which regions of light intensity of the image correspond to wells of the microtitre plate. An optical system is disposed within the plate reader body for expanding the distance to image plane of light, the optical system comprising a first mirror (15) disposed to receive light from the wells of the microtitre plate and reflect the light to second mirror (16) which is disposed to reflect incident light to the camera lens. The means for illumining the wells of the microtitre plate comprises a ring light (12) that embraces the camera and lens assembly.
Patent NZ-703820-A (NZ)
Title: Permeant delivery system and methods for use thereof
Inventor: ENSCORE DAVID
IPC: A61M37/00
Filed: 2009-03-31
Abstract: The present disclosure relates generally to the field of transdermal permeant delivery and more specifically to devices, systems and methods for using the same. More specifically the disclosure relates to patch for delivering a permeant through a biological membrane of a subject comprising: a) a matrix comprising two or more polymers; b) at least one hydrophilic permeant disposed within the matrix, wherein at least a portion of the hydrophilic permeant can dissolve in biological moisture received from the subject and c) at least one permeability enhancer disposed within the matrix. Or a system comprising the above that additionally comprises a porator
Patent NZ-703991-A (NZ)
Title: High-purity large-scale preparation of stannsoporfin
Inventor: DRUMMOND GEORGE S
IPC: C07F7/22
Filed: 2007-10-04
Abstract: Disclosed herein is the use of a composition comprising stannsoporfin, wherein said stannsoporfin is at least about 98.5% pure and wherein any individual impurity is present in an amount of less than about 0.1%, in the manufacture of a medicament for treating a condition selected from hyperbilirubinemia or elevated serum levels of bilirubin in an infant, wherein the medicament is to be administered by intramuscular injection to said infant; and wherein a therapeutically effective amount is from about 1.5 mg/kg to about 4.5 mg/kg birth weight of said infant. Also disclosed is a method for producing a tin (IV) mesoporphyrin compound or salt thereof comprising: (a) preparing a solution or suspension of mesoporphyrin IX dihydrochloride or a salt thereof by: (1) exposing a metallic hydrogenation catalyst to a hydrogen atmosphere to form a pre-hydrogenated catalyst, wherein the metallic hydrogenation catalyst is palladium on carbon; and (2) contacting hemin with the pre-hydrogenated catalyst and maintaining the hemin and catalyst under one or more combinations of temperature, hydrogen pressure, and time to remove iron from the hemin and to reduce the vinyl groups of the hemin to ethyl groups, thus forming mesoporphyrin IX, (3) isolating the mesoporohyrin IX as mesoproxphyrin IX formate; (4) purifying the isolated mesoporphyrin IX formate; (5) converting the purified mesoporphyrin IX formate into mesoporphyrin IX dihydrochloride: (6) treating the mesopoxphyrin IX dihydrochloridewith diatomaceous earth and activated carbon, then adding 0.1 to 6N HCI to the mesoporphyrin IX dichloride; (b) preparing a solution or suspension of tin (II) oxide, wherein steps (a) and (b) can occur in any order or simultaneously; (c) contacting the solution or suspension of tin (II) oxide with the solution or suspension of mesoporphyrin IX dihydrochloride or salt thereof by dropwise addition of the solution or suspension of mesoporphyrin IX dihydrochloride or salt thereof to form the tin (IV) mesoporphyrin compound or salt thereof; and (d) purifying the tin (IV) mesoporphyrin IX dichloride via hot acid trituration, followed by, treatment at high pH at or above pH 9 followed by re-acidification, and subsequent hot acid trituration.
Patent NZ-712109-A (NZ)
Title: Headgear assembly for a respiratory mask assembly
Inventor: AMARASINGHE AMAL SHIRLEY
IPC: A62B18/08
Filed: 2003-09-05
Abstract: A headgear assembly for stabilizing and positioning a respiratory mask assembly on a patient’s head, comprising: a pair of upper side straps (16) and a pair of lower side straps (24); a rear portion including an upper strap, a lower strap, and an intermediate strap arrangement between the upper and lower straps of the rear portion; and a stiffener (46) positioned on the rear portion, wherein the intermediate strap arrangement includes a pair of upper straps (32) angled with respect to the upper strap of the rear portion, a pair of lower straps (34) angled with respect to the lower strap of the rear portion, and a cross-bar strap (36) that extends between the upper and lower straps of the intermediate strap arrangement, wherein the stiffener includes a body (48) that extends along the cross-bar strap to assist in engagement of the cross-bar strap with the patient’s occipital bone, wherein the stiffener includes a pair of arm members (50) that extend along respective lower straps of the intermediate strap arrangement to resist movement between the cross-bar strap and the lower straps to prevent the lower straps from impinging on an inferior portion of the patient’s ear, and wherein the body has a width that is greater than a width of the arm members.
Patent NZ-717253-A (NZ)
Title: Urea and nitrogen stabilizer compositions
Inventor: GABRIELSON KURT DAVID
IPC: C05G3/90
Filed: 2014-08-25
Abstract: This invention relates to an improved urea-nitrogen stabilizer composition and methods, systems and apparatti for making thereof. The nitrogen stabilizer composition is incorporated into molten urea to result in a composition that contains less biuret, NMP, nitrogen stabilizer and/or impurities and provides an effective solid fertilizer. These compositions are useful in odor control.
Patent NZ-721364-A (NZ)
Title: Targeted tgfβ inhibition
Inventor: LO KIN-MING
IPC: C07K16/46
Filed: 2015-02-10
Abstract: This invention relates generally to bifunctional molecules including (a) a TGFβRII or fragment thereof capable of binding TGFβ and (b) an antibody, or antigen binding fragment thereof, that binds to an immune checkpoint protein, such as Programmed Death Ligand 1 (PD-L1), uses of such molecules (e.g., for treating cancer), and methods of making such molecules.
Patent NZ-722019-A (NZ)
Title: Bicyclic heterocyclyl derivatives as irak4 inhibitors
Inventor: GUMMADI VENKATESHWAR RAO
IPC: C07D413/14
Filed: 2015-01-12
Abstract: The present invention provides bicyclic heterocyclyl kinase enzyme inhibitor compounds of formula (I), which are therapeutically useful as kinase inhibitors, particularly IRAK4 inhibitors. wherein A, Y, Z, X1, X2, X3, R1, R3, ‘m’, ‘n’ and ‘p’ have the meanings given in the specification and pharmaceutically acceptable salt or stereoisomer thereof that are useful in the treatment and prevention of diseases or disorder, in particular their use in diseases or disorder mediated by kinase enzyme, particularly IRAK4 enzyme. The present invention also provides pharmaceutical composition comprising at least one of the compounds of compound of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient therefor.
Patent NZ-724915-A (NZ)
Title: Thermal energy metering using an enthalpy sensor
Inventor: VAN HOUTEN ARNOUD
IPC: G01K7/00
Filed: 2015-04-07
Abstract: Apparatus and methods are provided for thermal energy metering by measuring the average temperature of fluid in a tank, such as a hot water storage tank. Average temperature is measured with an elongated temperature sensor wire that can span the vertical height of the tank. The sensor wire can be protected with a waterproofing jacket. The sensor wire can be coupled to a second substantially parallel wire. A processing unit measures temperature from changes in the resistance of the sensor wire and measures rates of change to allow the system to distinguish different sources of heat increase and/or decrease.